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Skin neglected tropical diseases (NTDs) such as Buruli ulcer (BU) and leprosy produce sig-
nificant stigma and disability. Shared clinical presentations and needs for care present
opportunities for integrated case management in co-endemic areas. As global policies are
translated into local integrated services, there remains a need to monitor what new configu-
rations of care emerge and how individuals experience them.
Methods
To explore patient experiences of integrated case management for skin NTDs, in 2018, we
conducted a field-based qualitative case series in a leprosy rehabilitation centre in Ganta,
Liberia where BU services were recently introduced. Twenty patients with BU (n = 10) and
leprosy (n = 10) participated in in-depth interviews that incorporated photography methods.
We contextualised our findings with field observations and unstructured interviews with
health workers.
Findings
The integration of care for BU and leprosy prompted new conceptualisations of these dis-
eases and experiences of NTD stigma. Some patients felt anxiety about using services
because they feared being infected with the other disease. Other patients viewed the two
diseases as ‘intertwined’: related manifestations of the same condition. Configurations of
inter-disease stigma due to fear of transmission were buffered by joint health education ses-
sions which also appeared to facilitate social support between patients in the facility. For
both diseases, medication and wound care were viewed as the cornerstones of care and
appreciated as interventions that led to rehabilitation of the whole patient group through
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shared experiences of healing, avoidance of physical deformities and stigma reduction.
Patient accounts of intense pain during wound care for BU and inability of staff to manage
severe complications, however, exposed some shortcomings of medical care for the newly
integrated service, as did patient fears of long-lasting disability due to lack of physiotherapy
services.
Significance
Under integrated care policies, the possibility of new discourses about skin NTD identities
emerging along with new configurations of stigma may have unanticipated consequences
for patients’ experiences of case management. The social experience of integrated medica-
tion and wound dressing has the potential to link patients within a single, supportive patient
community. Control programmes with resource constraints should anticipate potential chal-
lenges of integrating care, including the need to ameliorate lasting disability and provide
adequate clinical management of severe BU cases.
Author summary
Buruli ulcer and leprosy are disfiguring diseases of the skin that lead to disability and
stigma. Although they are both present in overlapping population groups in West Africa,
efforts to care for people affected have usually had a single disease focus. Since both condi-
tions require wound care and long courses of medications, and the risk for transmission is
minimal, it has been recommended that they could be managed together. However, there
are few reports on how people affected by these diseases experience being brought
together.At the border between Liberia and Guinea, a rehabilitation centre has recently
integrated care for Buruli ulcer with leprosy care. We conducted a qualitative study in this
facility to explore experiences of integrated care for these two diseases. We found that peo-
ple experience these diseases in a similar way, to the extent that some considered both dis-
eases to be related, and perceive receiving their medications and wound care together
favourably.We identified some negative experiences including unjustified fear of acquir-
ing the other disease, intense pain during the process of wound cleaning, and permanent
disability due to lack of physiotherapy. In the future, programmes that implement inte-
grated care should anticipate and address these negative experiences to mitigate the bur-
den of these diseases.
Introduction
Skin neglected tropical diseases (NTDs) are a group of stigmatising and disability-inducing
infections that include leprosy, Buruli ulcer (BU), cutaneous leishmaniasis, lymphatic filariasis,
onchocerciasis, mycetoma, and yaws. These diseases present as chronic disruptions and alter-
ations of the skin barrier that cause significant scarring, burdening the lives of those affected
through reduced mobility, hindered productivity and psychological distress[1–4].
As highly visible diseases that affect a person’s aesthetic appearance, skin NTDs produce
social effects including stigma. Stigma is the social disqualification of individuals due to an
attribute that marks them as different from “normal” and links them to undesirable character-
istics[5,6]. Stigma may manifest as active experiences of social judgement and discrimination
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(“enacted stigma”), or as an internalised sense of shame and fear of encountering enacted
stigma (“felt stigma”)[7]. As infectious diseases, skin NTDs can also generate stigma based on
an exaggerated fear of danger and contagion[8]. While what is stigmatised and the forms that
stigma takes vary between cultures and conditions, an emerging literature on skin NTDs
increasingly recognises that stigma associated with these diseases inevitably shapes people’s
health and health-seeking behaviour and the effectiveness of disease control[6–9].
Although skin NTDs have different aetiologies and transmission routes, they share a need
for medically complex and multi-dimensional case management. This can include long
courses of chemotherapy, in-patient wound care, prevention of physical disability and psycho-
social support to achieve rehabilitation[4]. Traditionally, all skin NTDs have been managed
through single-disease vertical programmes that duplicate efforts in some areas and suffer sim-
ilar gaps in investment in others, resulting in fragmented and ineffective responses[10]. These
shared needs represent opportunities for integrated case management strategies that, if imple-
mented effectively, may contribute to reducing the burden of these diseases[11–14].
Recently, these opportunities have been translated into global policy recommendations for
integrated control programmes that aim to simultaneously address all co-endemic diseases
while increasing efficiency over stand-alone programmes[4]. Arguments in support of this
integrated approach include improving resource allocation, developing sustainable and flexible
expertise, and leveraging existing regional responses to co-endemic diseases[12,15]. As global
policies are translated into local integrated services, however, there remains a need to monitor
what new configurations of care emerge and how individuals receive them. Such insight would
ensure people’s experiences are kept at the forefront of programming, and provide depth and
richness about the context in which local NTD control programmes operate[16,17].
Liberia is endemic for several skin NTDs, including BU and leprosy. Emerging evidence
suggests that in this setting both diseases disrupt people’s lives through chronic illness, mor-
bidity and disability[18]. Towards establishing a centre of excellence for the management of
NTDs, the Ministry of Health has recently integrated BU care at a national leprosy rehabilita-
tion centre in Ganta, a town close to the northern border with Guinea[19]. The aim of this
qualitative study was to explore the experiences of in-patients affected by BU and leprosy
receiving integrated case management in this setting.
Methods
We conducted a field-based qualitative case series of patients with BU and leprosy receiving
care at the Ganta Tuberculosis & Leprosy Rehabilitation Centre in Nimba County, Liberia.
This methodological approach was chosen on the basis of conducting patient-centred research
in a clinical context. We used in-depth interviews with cases, daily field notes and photography
methods during six weeks of fieldwork between June and August 2018.
Study setting and population
The centre is a national referral facility that provides diagnostics, treatment, and management
for people of all ages with leprosy, BU, or tuberculosis. Established in the mid-1920s by Ameri-
can Methodist missionaries, the centre initially provided rehabilitation services for people
affected by leprosy, subsequently leading to a colony of people with leprosy in the surrounding
area. The centre incorporated tuberculosis care in the early 1990s during the First Liberian
Civil War. Based on WHO-driven initiatives to integrate case management for skin NTDs, the
Ministry of Health decided to upgrade the centre’s capacity, incorporating BU care with lep-
rosy care since 2015. Following the National Strategic Plan for the Case Management of NTDs,
centre staff was trained in laboratory diagnostics and care for BU[19].
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Members of the community or health workers refer potential patients affected by BU or lep-
rosy to the centre on the basis of clinical features. Suspected cases are confirmed upon arrival
at the centre using acid-fast bacilli (AFB) smears for both diseases. Most patients with BU and
leprosy are managed as in-patients and receive long-term care. Both patient groups cohabit
and receive care as a single group with shared facilities and health workers. Patients with suffi-
cient mobility might be managed as outpatients if they are able to commute daily for case man-
agement activities. Lodging and treatment for patients with tuberculosis occurs in a separate
building.
At the centre, patients with multi-bacillary leprosy, defined as having at least 5 skin lesions,
receive one year of multidrug therapy (MDT) with rifampicin, clofazimine and dapsone. Peo-
ple with pauci-bacillary leprosy (<5 lesions) receive MDT for six months. People with BU
receive 56 days of rifampicin plus clarithromycin or streptomycin, according to availability.
Both patient groups receive daily wound care for their lesions which include extensive skin
ulcers potentially leading to scarring and contractures in BU and neuropathic ulcers in leprosy
[4]. Other skin manifestations of leprosy such as skin patches and nodules do not require
wound care. All laboratory procedures, care activities, lodging and food provision are offered
free of charge to patients; funding is sourced from a variety of external donors including the
German Leprosy and Relief Association (GLRA), and coordinated via the Ministry of Health.
During the time of the fieldwork, approximately 90 patients with BU and 30 patients with lep-
rosy were receiving care at the centre.
In-depth interviews
We sought 20 patients (“cases”) with a diagnosis of BU (n = 10) or leprosy (n = 10). We
included patients who had received care at the centre for at least two weeks to ensure they had
experienced case management activities. We excluded patients with cognitive impairment that
could make interviewing difficult, and underage (<18 years) patients without the presence of a
guardian since they could not legally provide written informed consent.
During the first week of field work, potential participants were selected by a researcher
(MP) during informal conversations or via clinical chart review to identify patients that met
the inclusion criteria. We invited patients to participate in the study during delivery of chemo-
therapy and wound care services, or other activities in common areas in the centre. We purpo-
sively sampled participants across the range of ages, genders, languages and counties in the
sample to ensure maximum variability of experiences. Health workers did not have a role in
selecting potential study participants.
Interviews were semi-structured and focused on eliciting patients’ experiences of illness
and health-seeking before admission to the hospital, as well as experiences of case management
and rehabilitation after admission. During the first week of fieldwork, preliminary question
guidelines were validated with a subset of inpatients (n = 4) not included in the final study
dataset. We continued to refine interview guidelines during data collection to include addi-
tional probing on emerging themes. Interviews took place in a private office at the centre and
lasted between 38 and 60 minutes. All participants were interviewed in English by the first
author, with support of translators for local languages (Bere, Gio and Mano). To obtain rich
data, interviewing was conducted using respondent-centred approaches, applying interview
guidelines flexibly while allowing participants to take control of the conversation and using
probing techniques after their answers. All interviews were audio recorded. Information on
the gender, age, and diagnosis of cases was extracted from clinical charts.
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Field notes
The lead researcher’s observations, perceptions, and experiences of interacting with patients
and staff were collected as daily field notes or recorded as voice memos, and transcribed at the
end of each day. Unstructured conversations with five staff members (two nurses, one doctor,
one laboratory technician and one programme manager) were also included to contextualise
the content of in-depth interviews with patients.
Photography
The study involved the production of photographs as primary data. Using an instant camera
(Fujifilm Instax Wide), the case management setting, activities and routine procedures,
including lesions of patients, were documented during the study period. These photographs
did not include patients’ faces or identifying features. Additionally, photographs from
atlases of leprosy[20] and BU[21] were used to depict different categories of wounds. Dur-
ing in-depth interviews, both types of photos were integrated into the interview guideline
and shown to the study participants as physical prints. Discussions on what they saw,
thought, and experienced provided additional meaning to concepts elicited through verbal
questions.
Data management and analysis
Audio recordings from all in-depth interviews were transcribed using Microsoft Word 2016
(Version 16.13) with support from a multi-lingual research assistant. English portions of the
interviews were transcribed verbatim. Thematic analysis occurred simultaneously with data
collection. After six interviews, two clean transcripts were uploaded to Dedoose version 8.0, a
software for qualitative analysis. We used a first cycle of coding to develop a tentative code-
book and identify emerging themes, using primarily an inductive approach. Deductive coding
based on a literature review of patient medical and social experiences of skin NTDs from other
settings also contributed to initial codebook development. This codebook served as a provi-
sional start list to develop a case-theme matrix in Microsoft Excel 2016 (Version 16.16.15). The
matrix included rows for all cases and columns for each tentative theme, facilitating within-
case and across-case analysis. During fieldwork, excerpts from interview transcripts were
entered into the matrix in the appropriate case vs. theme cell using pattern coding. Matrix cells
also contained descriptive and analytic memos concerning the specific theme in the context of
each specific case. The matrix was rearranged and recompleted iteratively throughout the anal-
ysis process, as new themes emerged and others converged into larger themes. Thematic satu-
ration for main themes was reached by case 16, four additional cases were included aiming for
maximum variability in experiences. Themes were condensed into narrative descriptions of
findings. We reported our findings as patient experiences to avoid strictly biomedical interpre-
tations that might further remove future programming from users’ needs. While other
approaches, such as emphasising experiences of health workers and operational challenges for
programming are also needed, trustworthiness in the exploration of socio-cultural themes
such as stigma, disability, and rehabilitation required a patient-centred approach[17]. Repre-
sentative quotes were embedded within the results to exemplify themes, with minor grammati-
cal alterations to improve readability. Field notes and primary photographs were used to
complement descriptions and provide additional context[22]. Case vignettes and descriptions
were summarized in Table 1; clinical severity and disability classifications were reported
according to WHO guidelines[21].
Patient experiences of integrated BU and leprosy care in Liberia
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008030 February 5, 2020 5 / 16
Table 1. Case description and vignettes.
N˚ DIAGNOSIS SEX AGE OCCUPATION CASE DESCRIPTION� CASE MANAGEMENT�� COUNTY LANGUAGE
01 BU–Cat. III F 36 Business Two months of nodule with oedema and
small ulcers in right leg.





02 BU–Cat. III M 22 Driving student One month history of developing six large
ulcers in right leg.







03 MBL–G1D M 37 Judiciary Three years of plaques, nodules and home-
managed ulcer in limbs.













06 MBL–G0D M 21 High-school
student
One and a half year of skin patches and small
ulcer.
Two weeks at the centre.
Receiving WHO-MDT.
Received daily wound care.
Nimba English
07 BU–Cat II. M 22 High-school
graduate





08 MBL–G2D F 55 Rice farmer Two years of peripheral neuropathy in left
arm.




09 MBL–G2D F 66 Farmer Four years of peripheral neuropathy and
skin patches.






10 MBL–G2D F 20 Farmer Seven years of peripheral neuropathy. Ulcer
with osteomyelitis on left foot.
Seven months at the centre.
Surgery for complicated ulcer.
Daily wound care.
Lofa English
11 BU–Cat III. M 47 Construction
engineer
Three days of oedema and ulcer in right leg. Three months at the centre.
Receiving second course of
rifampicin + clarithromycin (56
days).
Weekly wound care as outpatient,
self-manages wounds at home.
Nimba English
12 BU–Cat III. M 42 Farmer Two weeks of extensive swelling and ulcer in
left arm.










14 BU–Cat III. M 15� Student Six months of extensive ulcers in both legs,
severe malnutrition and sepsis.
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Ethics
This study was approved by the Ethics Committees of the London School of Hygiene and
Tropical Medicine (15584) and the Liberian Ministry of Health (1802088). Those who
expressed interest to participate gave their written informed consent. As most participants
were illiterate, a research assistant ensured that participants understood the study procedures
thoroughly after a verbal explanation in the patients’ mother tongue. Patients who were under
18 years gave verbal informed assent, and were interviewed in the presence of guardians, who
gave written informed consent. Participants received a towel, a piece of soap, and a photograph
of themselves, equivalent to less than 2.00 USD as compensation for their time. All photo-
graphs were taken with the verbal consent of those depicted, including staff, and were shown
to them immediately, receiving favourable responses. Due to the stigmatising nature of BU
and leprosy, all photographs were produced in the ethical framework of representing vulnera-
ble subjects[23].
Results
We interviewed 20 people affected by BU (n = 10) and leprosy (n = 10); participant demo-
graphic and clinical characteristics are described in Table 1. Additionally, we entered 28 daily
entries as field notes, which included unstructured interviews with five health care workers.
Our results are presented in three sections which correspond to patient experiences of three
dimensions of care provided by the NTD programme: (1) health education, disease identities
and inter-disease stigma, (2) experiences of pain and healing through wound care and medica-
tion, and (3) experiences of rehabilitation addressing stigma and disability.
Table 1. (Continued)
N˚ DIAGNOSIS SEX AGE OCCUPATION CASE DESCRIPTION� CASE MANAGEMENT�� COUNTY LANGUAGE
15 MBL–G2D M 46 Security Two years of skin patches and numbness in
limbs.




16 MBL–G2D F 55 Farmer One year of numbness and weakness in
hands and feet, skin nodules and patches.




17 MBL–G2D M 42 Miner Five years of numbness in feet and skin
patches




18 BU–Cat III. F 60 Farmer Recurring episodes of oedema in both legs
since 2014, blister and ulcer in left leg for
three weeks.





19 BU–Cat III. M 17 Student Two months of oedema, blisters and ulcers
in both legs.





20 MBL–G2D F 47 Business Few days of oedema and skin nodules in face
and limbs.
Completed WHO-MDT as in-
patient.
Receiving corticosteroid therapy for
leprosy reaction type II.
Bong English
NOTES: BU = Buruli ulcer, MBL = Multibacillary leprosy, Cat = Category, G0D = Grade 0 Disability, G1D = Grade 1 Disability, G2D = Grade 2 Disability,
WHO-MDT = WHO Multidrug therapy
�At presentation in the centre
��At time of interview
https://doi.org/10.1371/journal.pntd.0008030.t001
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“Intertwining” disease identities and inter-disease stigma
Due to its history, the Centre and its surroundings had a negative reputation as a place of lep-
rosy, disability, and amputation. Participants mentioned that members of the centre’s sur-
rounding communities were sometimes labelled as “leprosy people”, which made others
scared of approaching the facility. The recent inclusion of BU care within a well-known leprosy
rehabilitation facility caused some apprehension among newcomers with BU, who anticipated
leprosy-related stigma:
“I was thinking that this place was only for leprosy, not for sores [ulcers] like this [. . .] I
said, so when I come, they will not cut [amputate] my foot?” (Case 013, BU, F, 51)
Some participants appeared unable to distinguish between the aetiologies of skin ulcers
from the two diseases, or felt distinguishing them was unnecessary. They perceived both con-
ditions to be “intertwined” or related to one another along a continuum of the same disease,
suggesting that the integration of care had created new dimensions in old discourses about
leprosy:
“Buruli ulcer and leprosy, they are intertwined. [. . .] When the Buruli ulcer, it stays long on
you, I think leprosy will join into it. Then your foot and other things will be gone [ampu-
tated], so they are intertwined. Because it is sore and caused by bacteria and diseases.”
(Case 007, BU, M, 22)
Other participants perceived the diseases as separate conditions but with similar attributes.
Leprosy was perceived to be more severe because of an expectation of amputation and social
discrimination. Such distinctions helped construct social identities that shaped notions of oth-
erness among patients with the different conditions within shared spaces:
“I have my infection, they have theirs, ok?” (Case 015, MBL, M, 46)
These notions of “them” and “us” shaped inter-disease stigma among both patient groups
within the centre, manifested as fear of acquiring the other disease. Some people affected by
BU reported “feeling sorry” for people with leprosy, and feared developing leprosy themselves.
This sometimes motivated them to use outpatient rather than the integrated inpatient care
unit, and made them avoid common bathrooms and mosquito bites in the centre, both
thought to facilitate leprosy transmission:
“The reason [I stay home] is that I have Buruli. You have leprosy, then you laying down as a
leprosy patient, then I am laying down as a Buruli patient. Mosquito, is able to bite you, and
come and bites me. So, the fear is that the person who has leprosy and the person who has
ulcer can’t be in one place. I am afraid.” (Case 011, BU, M, 47)
Stigma was bidirectional, as newcomers with leprosy also avoided people in early stages of
BU treatment due to the smell of the ulcers and fear of transmission:
“First I was afraid they were going to put me in a room with some of the patients that have
the sore. I said to the people: I’m not sleeping there, I’m not gonna get the sore too.” (Case
006, MBL, M, 21)
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Health workers, however, pointed out that inter-disease stigma seemed to be buffered over
time by morning health education sessions, where information about BU and leprosy trans-
missibility was frequently discussed. This knowledge was evident among some participants
who described leprosy as not transmissible after patients receive medication, and that BU was
transmissible by walking in swamps but not from person to person. Morning sessions also
facilitated relationship-building among people with similar backgrounds but different diseases
thereby encouraging communal living. This was apparent in the case of a man with BU who
frequently spent time with a man affected by leprosy. Both young men were from Guinea and
were learning English during their time at the centre. After asking for a portrait of them taken
together, the man with BU described the photograph as follows:
“This is me. And my Guinea man. Leprosy man. From Guinea. My friend.” (Case 002, BU,
M, 22).
Establishing an intertwined patient community helped people from both disease popula-
tions to support each other emotionally and instrumentally throughout integrated medical
activities, discussed next.
Medication and dressings: Experiences of integrated chemotherapy and
wound care
Most participants were aware of differences in the types of medication and wound care
required for each disease. Both patient groups experienced receiving daily medication as the
cornerstone of their rehabilitation: tablets and pills were described as effective and appreciated
for their ability to remove illness and its attached social burden. Medication inspired hope
about a future without disease:
"I feel comfortable, when there’s life, there is hope. Because I am going through medication,
and you know my time is not yet over." (Case 015, MBL, M, 46)
Though their one year course of medication was perceived as lengthy, people with leprosy
framed completing it as necessary to restore their social identities:
“I will say (to others in the community): I took the medicine and I don’t get any sickness
now. You must not be afraid of me, you come around me, the way we were joking before, it
will be like that now." (Case 009, MBL, F, 66)
A few people with BU experienced only limited wound improvement and maintained posi-
tive AFB smears, requiring a second course of treatment with the same regimen. This caused
some to doubt the treatment efficacy:
"What I believe in my mind is that BU has no good treatment yet, they have not discovered
it for this sickness.” (Case 011, BU, M, 47)
Dressing of skin ulcers was provided simultaneously to all people affected by BU and a
minority of those with leprosy. Discussions about this activity emotively described the enacted
stigma people experienced associated with smell:
“The way of the sore, and the smell of it, people don’t want to sit around you. Yeah, they
think they might get it, they think it’s transferrable.” (Case 006, MBL, M, 21)
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Both groups perceived wound cleaning and dressing as healing by taking away germs,
replacing foul smelling bandages, and avoiding flies and felt this helped people avoid stigma.
Attitudes towards wound care were also shaped by experiences of pain, which were promi-
nent during the initial stages of wound cleaning. Upon admission, people with skin ulcers
underwent manual debriding consisting of removal of necrotic tissue, fluid, and plasters of
mud remaining from traditional medicine practices. Some participants interpreted the reduc-
tion of pain throughout the wound care process as evidence of improvement, or as a necessary
experience to achieve cure, as discussed by a woman with BU while describing a photograph of
the wound care room:
“In this place they can change the bandage, and this is the place I said that day that you
must take my picture so it can be remembered, because I suffered under this thing [Buruli
ulcer] too much [. . .] So I want you to give me the picture when I go, then I can show it to
my children, in this place I was cured”. (Case 013, BU, F, 51)
Patients with severe BU required squeezing and draining of subcutaneous accumulations of
fluids. Pain management was limited to injection of intramuscular diclofenac, the strongest
analgesic available. Instances of screaming, intense agitation, and fainting were observed dur-
ing fieldwork and documented in participants’ testimonies. Such experiences contributed to
occasional refusal or resistance to participate in wound care activities. This was the case of a
young man with BU frequently seen arguing with staff during wound cleaning. He described a
photograph of patients queueing outside the wound care room as follows:
“The time we can be going for dressing our hearts can be beating, we [are] going [to] feel
pain here. Any time we see this place, each time we know our hearts can be disturbed.”
(Case 019, BU, M, 17)
People with large wounds due to BU often arrived at the centre presenting with fever,
infected wounds in need of antibiotics, and severely malnourished, especially after prolonged
and unsuccessful experiences with traditional medicine, as expressed by the mother of a young
boy with extensive BU lesions in both legs:
“That was four months we made there [spent at the herbalist], it was not working, he was
just reducing the body, (. . .) losing weight.” (Case 014, BU, M, 15)
Such severe cases required surgical management such as amputation, skin grafting or exten-
sive debridement under anaesthesia, which, theoretically, could be coordinated via referral to a
neighbouring hospital. However, staff complained that they were discouraged from organising
referrals because of resistance from staff at receiving facilities who feared disease transmission
or cited limited resources to cover surgical costs.
Complicated cases such as these thus challenged the centre’s management capacity. The
boy severely affected by BU described above died the day after participating in an interview
due to sudden onset of diarrhoea and dehydration complicating his vulnerable state. Lack of
emergency equipment, overnight medical staff, and capacity to establish a central venous cath-
eter impaired adequate shock management. In the aftermath of the emergency, two health
workers admitted that deaths from shock and complications among people severely affected
by BU was a recurrent and particularly distressing problem.
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“Small, small”: Progressive visible improvement, normalisation and
rehabilitation
Notwithstanding instances such as the one described above, favourable experiences of case
management dominated participants’ narratives; these emphasised the external visibility of
improvements and the reduction of felt stigma and the anxiety caused by anticipated stigma.
Testimonies highlighted the noticeable closing of open sores in BU and disappearing of skin
marks in leprosy as desirable outcomes of treatment. This was highlighted by a participant
describing the experience of a family member who previously received early treatment for lep-
rosy, and whose favourable results included resuming economic productivity and avoiding
social isolation due to lack of discrediting scarring:
“A decent man, he’s working! The whole fingers correct, the toes correct, everything on
him is fine! No problem, you can’t even know he had leprosy." (Case 006, MBL, M, 21)
Improvements in mobility and decreasing dependence on assistive devices such as wheel-
chairs, crutches and walking sticks were also emphasised in participant’s narratives. Affected
limb movement and function was facilitated by patient’s own motivations to resume social
and economic productivity, and by participants’ fear that their bodies would be permanently
disabled. Testimonies about the rehabilitation process also acknowledged deficits in the cen-
tre’s programming. While assistive devices were available from a local workshop that facili-
tated makeshift wheelchairs and shoewear, formal physiotherapy services including guidance
in rehabilitative exercising were not available due to understaffing. Weekly medical rounds
focused on individual adherence to chemotherapy and continuous wound care, and tended to
neglect physical rehabilitation plans to prevent lasting functional disability. This had severe
consequences for some people affected by BU, for whom a lack of physiotherapy and guidance
led to disfigurement potentially incompatible with productivity:
“I can’t come back to my normal stage (. . .) The way I used to work with my two hands, it
will not be like that way now. Maybe sometime, if I don’t get some family to help me, to get
some money, to make little business and then sit down. . . I will not be working hard again,
that’s the only thing I am thinking about, the work.” (Case 012, BU, M, 42)
Overall, patients appreciated the long-term commitment to care that the programme and
staff provided. Both groups of participants referred to these improvements using the phrase
“small-small” to signify how cure occurred slowly, but surely:
“They started to dressing me every morning, give me medicine, they are doing well. At least
I can see myself moving on my feet now small, small.” (Case 001, BU, F, 36)
Case management at the centre was described as a rehabilitating and “normalising” experi-
ence that addressed both disability and stigma, as exemplified by a man with BU while discuss-
ing a photo of a patient waiting area:
"People who come here are people who are getting well [. . .] They [are] able to walk by
themselves [. . .] They feel that they are getting normal, they are getting better.” (Case 011,
BU, M, 47)
Furthermore, bringing together both patient groups in a single facility for this treatment
had the effect of blurring the lines between disease identities, not only shaping unique
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configurations of inter-disease stigma, but also linking patient groups within a single patient
community. This was verbalised by the mother of the boy with BU who died, who described
the way integration of care in one facility intertwined disease identities in the collective
imaginary:
“The sore people and the leprosy people they are one, they are in one place.” (Case 014, BU,
M, 15)
Discussion
In this qualitative study, we explored patients’ experiences of integrated case management of
BU and leprosy in a referral in-patient facility in Liberia. Our study is among the first to docu-
ment patient experiences of multiple skin NTDs in a specialised clinical centre. Upon integra-
tion of care, disease identities of people with these skin NTDs intertwined, reshaping old
discourses and configuring inter-disease stigma. Overall, case management activities appeared
to adequately address the burden of both diseases, slowly rehabilitating people’s “spoiled”
social identities by tackling stigma and disability[24]. Moreover, the long-term, shared and
occasionally intense social experiences of medication and wound dressing created a patient
community that supported patients with both diseases. Negative experiences of integrating BU
care in a leprosy facility with limited resources, however, included long-lasting disability due
to lack of physiotherapy services, suboptimal pain management during wound care, and life-
threatening complications among severe cases of BU. These experiences are expressions of
actionable implementation challenges that should be considered in the design of people-cen-
tred approaches.
While integrated approaches to the case management of skin NTDs have been imple-
mented in co-endemic areas, few health systems have documented actual experiences of imple-
mentation[25]. A case study in Ethiopia reported the managerial feasibility of integrating
morbidity management of tropical lymphedema caused by lymphatic filariasis (LF) and podo-
coniosis[26]. Patient experiences of integrated care for leprosy and BU in Cote d’Ivoire[25], LF
and leprosy in Nepal[27], and multiple skin NTDs in Liberia[18] have been explored in com-
munity settings, but studies investigating the social experience of integrated case management
in facility settings are lacking. To our knowledge, our study is the first to examine patient expe-
riences of integrated clinical case management of skin NTDs.
We found positive experiences of receiving integrated case management among people
affected by BU and leprosy. Participants’ testimonies unveiled common experiences of illness
and shared needs for holistic care, including physical rehabilitation: these shared social experi-
ences further enabled integration. While at a global level, the justification to integrate pro-
grammes for skin NTDs is primarily logistical or resource considerations[4,15], here, we
demonstrate that shared experiences of morbidity, disability and stigma also facilitate inte-
grated approaches to case management, and enhance their feasibility.
Our findings suggest that service integration might have an unanticipated effect on disease
identities, leading to the intertwining of leprosy and BU in patient’s discourses and inter-dis-
ease stigma. Based on these findings, we hypothesize that as skin NTD programmes transition
towards integration, the way people perceive and experience these diseases might change,
affecting stigma and potentially also health-seeking behaviour. While enacted and felt stigma
have been extensively documented for skin NTDs[28,29], there is limited documentation of
inter-disease stigma. This phenomenon had been anticipated in a community-based study in
Nepal that explored attitudes towards integrating care among people with LF and leprosy,
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finding perceptions of stigma concerning the alternate condition[30]. In agreement, our findings
on inter-disease stigma reinforce that the integration of case management for skin NTDs should
anticipate this phenomenon in mixed patient communities. While constant contact between
both patient communities may eventually help reduce stigma[31], the experiences described at
Ganta suggest that inter-disease stigma might also be actively addressed by health education ses-
sions. These should be focused on mitigating fear of transmission, and delivered from the onset
of integrated case management. Additionally, experiences of cross-disease community building
suggest that interventions that leverage social support might also be effective in buffering both
disease-specific and inter-disease stigma. Our findings support experiences from “therapeutic
communities” as part of BU management in Benin[32], and highlight the need for psychosocial
interventions in which patients cross-support each other in their path towards rehabilitation.
Our study identified negative experiences of case management in a resource-constrained
setting, which include limited rehabilitation due to lack of physiotherapy services and experi-
ences of intense pain and death among people with BU. Liberia’s history of civil war, Ebola,
and socio-political context shape a weakened health system in which effective programme
implementation is challenging[33,34]. While broader health-system strengthening is needed,
these particular implementation challenges can be directly targeted. People with severe BU
might require complex management due to life-threatening and painful complications includ-
ing secondary bacterial infections, sepsis, and shock[35]. Establishing protocols and algorithms
for pain management, referral of complex cases, and shock management is urgently needed to
avoid recurrence. Additionally, holistic approaches to case management that focus on social
rehabilitation and not solely on biomedical or operational outcomes (e.g. negative smears or
treatment completion) are needed to prevent lasting disability and stigma[12,36,37]. This
should include streamlining quality rehabilitation services during in-patient care with follow
up community-based rehabilitation upon discharge[38].
This study had some limitations. As a health facility-based study, people in the community
who did not access care were not represented in the study sample. While understanding expe-
riences of integrated case management implied recruiting inpatients, this approach might have
excluded people who fear seeking care due to stigma and who might have experienced inte-
grated case management differently. Future community-based studies on integrated case man-
agement for skin NTDs are needed. Additionally, the interviewer did not speak Gio, Bere, or
Mano. Language, gender and cultural differences might have affected experiences shared due
to positionality and social desirability. The use of photography and fluent translators well
known in the facility might have bridged some of these barriers.
Conclusion
Based on patient experiences, integrating case management of leprosy and BU in this context
appears to be effective in addressing the needs of people affected by these diseases. Integration
was experienced positively by patients, but reshaped discourses on disease identity around
unique inter-disease stigma configurations. Patients experienced consequences of limited
resources, such as lack of support to reduce lasting disability, and poor management of BU
complications.
Our study further supports the role of applied social sciences in locating people’s experi-
ences at the forefront of programme design and implementation. Future social science
research should study how stigma is shaped and performed under the new integration para-
digm for the management of skin NTDs. Further patient-centred research and health system
strengthening are needed to support the continued development of sustainable and coherent
integrated care programmes for these diseases.
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